Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.1.145

Common Variations of DNA Repair Genes are Associated with Response to Platinum-based Chemotherapy in NSCLCs  

Li, Xian-Dong (Department of Respiratory Medicine, Huaihe Hospital, Henan University)
Han, Ji-Chang (Department of Respiratory Medicine, Huaihe Hospital, Henan University)
Zhang, Yi-Jie (Department of Respiratory Medicine, Huaihe Hospital, Henan University)
Li, Hong-Bing (Department of Respiratory Medicine, Huaihe Hospital, Henan University)
Wu, Xue-Yan (Department of Respiratory Medicine, Huaihe Hospital, Henan University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.1, 2013 , pp. 145-148 More about this Journal
Abstract
Aim: Individual differences in chemosensitivity and clinical outcome of non-small-cell lung cancer (NSCLC) patients may be induced by host inherited factors. We investigated the impact of XPD Arg156Arg, XPD Asp312Asn, XPD Asp711Asp and XPD Lys751Gln gene polymorphisms on the efficacy of platinum-based chemotherapy in NSCLC patients. Methods: A total of 496 were consecutively selected from the Affiliated Hospital of Nantong University between Jan. 2003 and Nov. 2006, and all patients were followed-up until Nov. 2011. The genotyping of XPD Arg156Arg, XPD Asp312Asn, XPD Asp711Asp and XPD Lys751Gln was conducted by duplex polymerase-chain-reaction with the confronting-two-pair primer methods. Results: Individuals with XPD 312 C/T+T/T and XPD 711 C/T+T/T exhibited poor responses to chemotherapy when compared with the wild-type genotype, with adjusted ORs(95% CI) of 0.67(0.38-0.97) and 0.54(0.35-0.96), respectively. Cox regression showed the median PFS and OS of patients of XPD 312 C/T+T/T genotype and XPD 711 C/T+T/T genotype to be significantly lower than those with wild-type homozygous genotype. Conclusion: We found polymorphisms in XPD to be associated with response to platinum-based chemotherapy in NSCLC, and our findings provide information for therapeutic decisions for individualized therapy.
Keywords
Xeroderma pigmentosum group D; polymorphism; non-small cell lung cancer; chemotherapy; response;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Gurubhagavatula S, Liu G, Park S, et al (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-smallcell lung cancer patients treated with platinum chemotherapy. J Clin Oncol, 22, 2594-601.   DOI   ScienceOn
2 International Agency for Research on Cancer (2008). Lung cancer incidence, Mortality and Prevalence Worldwide in 2008. http://globocan.iarc.fr/factsheet.asp.
3 Lord RVN, Brabender J, Gandara D, et al (2002) Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Clin Cancer Res, 8, 2286-91.
4 Lunn RM, Helzlsouer KJ, Parshad R, et al (2000). XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis, 21, 551-5.   DOI   ScienceOn
5 Mi Y, Zhang L, Feng N, et al (2012). Impact of Two Common Xeroderma Pigmentosum Group D (XPD) Gene Polymorphisms on Risk of Prostate Cancer. PLoS One, 7, e44756.   DOI
6 Monaco R, Rosal R, Dolan MA, et al (2009). Conformational effects of a common codon 751 polymorphism on the Cterminal domain of the xeroderma pigmentosum D protein. J Carcinog, 8, 12.   DOI   ScienceOn
7 J Carcinog, Provencio M, Camps C, Cobo M, et al (2012). Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer. Cancer Chemother Pharmacol, 70, 883-90.   DOI   ScienceOn
8 Schiller JH, Harrington D, Belani CP, et al (2002). Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med, 346, 92-8.   DOI   ScienceOn
9 Spitz MR, Wu XF, Wang YF, et al (2001). Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res, 61, 1354-7.
10 Wei S-Z, Zhan P, Shi M, et al (2011). Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis. Med Oncol, 28, 315-21.   DOI   ScienceOn
11 William WN Jr, Lin HY, et al (2009). Revisiting stage IIIB and IV non-small cell lung cancer: Analysis of the surveillance, epidemiology, and end results data. Chest, 136, 701-9.   DOI   ScienceOn
12 Wolfe KJ, Wickliffe JK, Hill CE, et al (2007). Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression. Pharmacogenet Genom, 17, 897-905.   DOI
13 Wu Q, Christensen LA, Legerski RJ, et al (2005). Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. Embo Reports, 6, 551-6.   DOI   ScienceOn
14 Yin M, Yan J, Voutsina A, et al (2011). No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis. Lung Cancer, 72, 370-7.   DOI   ScienceOn
15 Zhang ZY, Tian X, Wu R, et al (2012). Predictive role of ERCC1 and XPD genetic polymorphisms in survival of Chinese non-small cell lung cancer patients receiving chemotherapy. Asian Pac J Cancer Prev, 13, 2583-6.   DOI   ScienceOn
16 Ada AO, C Kunak S, Hancer F, et al (2010). CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients. Neoplasma, 57, 512-21.   DOI
17 Azuma K, Komohara Y, Sasada T, et al (2007) Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Sci, 98, 1336-43.   DOI   ScienceOn
18 Duan XL, Gong H, Zeng XT, et al (2012). Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 13, 3299-303.   DOI   ScienceOn
19 Butkiewicz D, Drosik A, Suwiński R, et al (2012). Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy. Int J Cancer, 131, E1100-8.   DOI   ScienceOn